Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry
Europace · 2024
DOI: 10.1093/europace/euae237 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, 2024. Verfasst von Rungroj Krittayaphong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Rd, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Atrial Fibrillation, Registries. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Systems Research Institute, Heart Association of Thailand, Royal Patronage of H.M . the King.
Abstract (Originalsprache)
Aims
Compliance with integrated care based on the Atrial fibrillation Better Care (ABC) pathway has been associated with improved clinical outcomes. The primary objective of this study was to compare clinical outcomes of AF patients according to the compliant status of each component of the ABC pathway in a hierarchical win ratio approach. Methods and results We studied AF patients in the COOL-AF registry. Each patient was followed every 6 months until 3 years. A win ratio analysis was performed, as not all clinical outcomes are equivalent. The hierarchical outcomes were (1) all-cause death, (2) intracranial haemorrhage (ICH), (3) ischaemic stroke/systemic embolism, (4) non-ICH major bleedings, and (5) acute myocardial infarction or heart failure. We also assessed win ratio and win proportion variance over the follow-up time, and the variations over time. A total of 3405 patients (mean age 67.8 ± 11.3; 41.8% female) were studied. Win ratio of ABC-compliant (all three components) vs. ABC-not-compliant was 1.57 (1.35–1.83), P < 0.001. When adding time in therapeutic range (TTR) data for compliant criteria for those who were on warfarin, the win ratio increased to 2.28 (1.89–2.75), P < 0.001. The A-compliant group (plus TTR data), B-compliant, and C-compliant had the win ratio of 1.81 (1.51–2.12), 1.82 (1.53–2.16), and 1.39 (1.18–1.62), all P < 0.001, compared to not compliant group.
Conclusion
Management of AF patients according to each component of the ABC pathway is associated with better clinical outcomes compared to those non-compliant to ABC pathway. This finding underscores the importance of a holistic management approach strategy for AF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Rd, Bangkok 10700, Thailand.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
- Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Rungroj Krittayaphong, Sukrit Treewaree, Gregory Y H Lip
Förderung
- Health Systems Research Institute
- Heart Association of Thailand
- Royal Patronage of H.M . the King
Zitieren
APA
Krittayaphong, R., Treewaree, S., & Lip, G. Y. H. (2024). Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry. Europace. https://doi.org/10.1093/europace/euae237
Vancouver
Krittayaphong R, Treewaree S, Lip GYH. Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry. Europace. 2024. doi:10.1093/europace/euae237
BibTeX
@article{Krittayaphong2024,
author = {Krittayaphong, Rungroj and Treewaree, Sukrit and Lip, Gregory Y H},
title = {Components of the Atrial fibrillation Better Care pathway for holistic care of patients with atrial fibrillation: a win ratio analysis from the COOL-AF registry},
journal = {Europace},
year = {2024},
doi = {10.1093/europace/euae237}
}
EUVIMED